Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael

Showing results (1221-1230 of 1,257) with videos related to

Pageof 126
Sort By:
Lancet (London, England)|October 25, 2025
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trialJohn Deanfield, A Michael Lincoff, Steven E Kahn, et al.
Frontiers in Public Health|October 31, 2025
Improving health professionals' capacity to respond to the climate crisis in Africa: outcomes of the Africa climate and health responder courseDanielly de P Magalhães, Cecilia Sorensen, Nicola Hamacher, et al.
The New England Journal of Medicine|November 17, 2009
Intravenous platelet blockade with cangrelor during PCIDeepak L Bhatt, A Michael Lincoff, C Michael Gibson, et al.
JAMA|November 7, 2002
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trialA Michael Lincoff, Robert M Califf, Frans Van de Werf, et al.
European Heart Journal|March 28, 2012
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics studyDeepak L Bhatt, Guillaume Paré, John W Eikelboom, et al.
Journal of Personality|June 11, 2021
Positive and negative urgency as a single coherent construct: Evidence from a large-scale network analysis in clinical and non-clinical samplesJoël Billieux, Alexandre Heeren, Lucien Rochat, et al.
American Heart Journal|May 17, 2026
Cardiovascular Regulatory Science: Accelerating the Path from Bench to BedsideSerge Korjian, C Michael Gibson, Jonathan Seltzer, et al.
European Heart Journal|May 7, 2014
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled TrialA Michael Lincoff, Matthew Roe, Philip Aylward, et al.
American Heart Journal|December 6, 2021
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE studyShalender Bhasin, A Michael Lincoff, Shehzad Basaria, et al.
The New England Journal of Medicine|November 25, 2006
Bivalirudin for patients with acute coronary syndromesGregg W Stone, Brent T McLaurin, David A Cox, et al.
Pageof 126

Showing results (1221-1230 of 1,257) with videos related to

Sort By:
Pageof 126
Lancet (London, England)|October 25, 2025
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trialJohn Deanfield, A Michael Lincoff, Steven E Kahn, et al.
Frontiers in Public Health|October 31, 2025
Improving health professionals' capacity to respond to the climate crisis in Africa: outcomes of the Africa climate and health responder courseDanielly de P Magalhães, Cecilia Sorensen, Nicola Hamacher, et al.
The New England Journal of Medicine|November 17, 2009
Intravenous platelet blockade with cangrelor during PCIDeepak L Bhatt, A Michael Lincoff, C Michael Gibson, et al.
JAMA|November 7, 2002
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trialA Michael Lincoff, Robert M Califf, Frans Van de Werf, et al.
European Heart Journal|March 28, 2012
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics studyDeepak L Bhatt, Guillaume Paré, John W Eikelboom, et al.
Journal of Personality|June 11, 2021
Positive and negative urgency as a single coherent construct: Evidence from a large-scale network analysis in clinical and non-clinical samplesJoël Billieux, Alexandre Heeren, Lucien Rochat, et al.
American Heart Journal|May 17, 2026
Cardiovascular Regulatory Science: Accelerating the Path from Bench to BedsideSerge Korjian, C Michael Gibson, Jonathan Seltzer, et al.
European Heart Journal|May 7, 2014
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled TrialA Michael Lincoff, Matthew Roe, Philip Aylward, et al.
American Heart Journal|December 6, 2021
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE studyShalender Bhasin, A Michael Lincoff, Shehzad Basaria, et al.
The New England Journal of Medicine|November 25, 2006
Bivalirudin for patients with acute coronary syndromesGregg W Stone, Brent T McLaurin, David A Cox, et al.
Pageof 126